Phathom Pharmaceuticals, Inc.
PHAT· Nasdaq
PHATPhathom Pharmaceuticals, Inc.
Filed Feb 28, 2023 · 10-K · 59 days after period end · 0000950170-23-004875
derived · Computed from the longer spans the company filed.
| Metric | Q4 2022dderived from reported figures | Q4 2021dderived from reported figures | Q4 2020 | Q4 2019 |
|---|---|---|---|---|
| Net Income | -$55.05M | -$35.83M | -$53.72M | -$98.01M |
| EPS Diluted | — | — | -$1.58 | -$3.97 |
The same fiscal quarter, prior years. Thaler holds no estimates to compare against.
Phathom Pharmaceuticals, Inc. · CIK 1783183 · Engraved from SEC EDGAR
ended Dec 31, 2022 · filed Feb 28, 2023 · 59 d after period end
